| Filed On | Filing |
|---|---|
| 29 Jul 2026 |
8-K/A: Financial Statements and Exhibits
CERTAIN INFORMATION CONTAINED IN THIS AGREEMENT HAS BEEN OMITTED BY MEANS OF REDACTING A PORTION OF THE TEXT AND REPLACING IT WITH [***] BECAUSE IT IS BOTH: (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONF... |
| 05 Feb 2026 |
8-K/A: Financial Statements and Exhibits
On January 30, 2026, Standard BioTools Inc. (the "Company") completed the sale of all of the equity interests of SomaLogic, Inc. (“SomaLogic”), Sengenics Corporation LLC, and Sengenics Corporation Pte Ltd (collectively, the "Disposed Ent... |
| 19 Jan 2024 |
8-K/A: Financial Statements and Exhibits
To the Stockholders and the Board of Directors of SomaLogic, Inc. |
| 11 Feb 2022 | 8-K/A: Financial Statements and Exhibits |
| 06 Sep 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 02 Aug 2019 | 8-K/A: Results of Operations and Financial Condition |
Loading...
